Drug Approval | December 12, 2022
Zydus receives USFDA approval to market Silodosin and Pregabalin capsules
Silodosin capsules treat signs and symptoms of an enlarged prostate gland
Silodosin capsules treat signs and symptoms of an enlarged prostate gland
The hospital is being developed at a cost of more than Rs. 1,575 crore
Since inception, more than 3.6 crore pregnant women have received comprehensive ANC under this programme across all states and UTs
This one-of-a-kind ophthalmic subspecialty division is focused on the treatment of the eye condition glaucoma
As a result, Imago will become a subsidiary of Merck.
Patients receiving Polivy plus R-CHP for DLBCL reported similar health-related quality of life outcomes
48-week data from MOMENTUM phase III clinical trial show momelotinib maintained total symptom response
GlobalData predicts the average prices of dual chamber pacemakers in both India and China are expected to reduce at an average CAGR of -3.42% from 2022 to 2025.
The approval follows the positive recommendation from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) in October 2022
Anandiben Patel, Governor, Uttar Pradesh will inaugurate the two-day celebrations
Subscribe To Our Newsletter & Stay Updated
